N-(6,7-Dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-d-aspartate receptor antagonists for the treatment of pain

Barry Finzel, Xinmin Gan, Sheila Guppy, Gregg Kamilar, Kenneth Kilgore, Pil Lee, Cho-Ming Loi, Zhen Lou, Mark Morris, Laurence Philippe, Sally Przybranowski, Frank Riley, Brian Samas, Brian Sanchez, Haile Tecle, Ziqiang Wang, Kathryn Welch, Michael Wilson, Karen Yates, Christopher Deur, Arun K. Agrawal, Heidi Baum, John Booth, Susan Bove, Joan Brieland, Amy Bunker, Cleo Connolly, Joseph Cornicelli, JoAnn Dumin
  • Bioorganic & Medicinal Chemistry Letters, August 2007, Elsevier
  • DOI: 10.1016/j.bmcl.2007.05.083
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Professor Barry C Finzel